![](/img/cover-not-exists.png)
A Phase I, Multicenter, Open-Label, First-in-Human, Dose-Escalation Study of the Oral Smoothened Inhibitor Sonidegib (LDE225) in Patients with Advanced Solid Tumors
Rodon, J., Tawbi, H. A., Thomas, A. L., Stoller, R. G., Turtschi, C. P., Baselga, J., Sarantopoulos, J., Mahalingam, D., Shou, Y., Moles, M. A., Yang, L., Granvil, C., Hurh, E., Rose, K. L., Amakye, DVolume:
20
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-1710
Date:
April, 2014
File:
PDF, 568 KB
english, 2014